It was highly expressed in adult AML patients’ exosomes, and TGFβ-1 exosomal expression was associated with a reduction in natural killer cell cytotoxicity (p < 0.002) [96], similar to what was reported for immunomodulation. Here, TGFB1 is linked to acute myeloid leukemia.